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Membrane-bound proteins owe their retention and conFo~ation in the lipid bilayer to hydrophobic peptide 
domains. Additional fixation, by protein-lipid hydrogen bonding, has been suggested, and recent reports 
on protein kinase C activation by diacylgly~ro~ (DC) provide an unambiguous model for such bonding. 
The sn-1,2-diacylgfyeerol appears to donate a hydrogen bond from the m-3 hydroxyl to the enzyme and 
to receive two hydrogen bonds, in the sn-1 and sn-2 ester CO groups, from the enzyme. This arrangement 
is confirmed in phorbol ester, a competitive inhibitor of DG for the kinase. This tumor promotor has a 
nearly identical spatial arrangement of hydrogen bond donor (PwOH) and acceptors (12 and 13 ester CO); 
so have two other tumor promotors, teleoeidin and aplysiatoxin. There are reasons to believe that protein 
kinase C is not the only protein that is bound to membrane lipids by hydrogen bonding, and such bonding 
will have to be considered in m~brane-ass~iat~ events such as fusion, cross-membrane transport, or 
anesthesia. 
Lipid-protein bonding Hydrogen bonding Diglyceride Protein kinase C Phorbol ester Apfysiato~in 
Te~eocidi~ e~ucose~~phosphat~e 
The ubiquitous phosphorylating enzyme, protein 
kinase C, binds to lipid biiayers with an affinity 
greatly enhanced by the combined presence of 
anionic lipid (especially phosphatidylserine) and 
diacylgly~eroi (DG) [l-4]. This uncharged lipid 
also increases the affinity of a third co-factor, 
Ca2+, for the enzy me, bringing the calcium re- 
quirement down to physiologicat levels (-1 FM) 
[3,4]. The structure of the diacyiglycerol is very 
critical: the length and degree of saturation of the 
fatty esters are not very important [I 5-71, but 
ether bonds in sn-1 and sn-2 positions of the 
glycerol are not acceptable [7] and the sn-3 OH 
group is irreplaceable [6]. Also, the lipid-enzyme 
association is stereospecific: only sn-I ,2-DG, but 
not its stereoisomer, sn-2,3-DG, is active [f&9]. 
Therefore, there must be 3-point fixation of the 
lipid to the protein, and since diacylglycerol has 
only three possible bonding sites there is no room 
for ambiguity: the C = 0 oxygens in position sn-1 
and ~~2-2 receive hydrogen-bonding protons from 
the DG-receiving site of the enzyme, and the sn-3 
OH group of DG donates a hydrogen bond to a 
receiving atom, probably a C = 0 oxygen, on the 
enzyme (fig.lb). 
More evidence, if it is needed, for the triple 
hydrogen bonding from the lipid effector to the 
kinase is supplied by certain tumor promotors. 
Phorbol diesters, in particular, compete with 
diglyceride for binding to the kinase [lo- 15). They 
might then show the same spatial bonding pattern 
of one hydrogen bond donating and two accepting 
groups (though it is not implied that every com- 
petitor must necessarily bond to all three sites). A 
space-filling model of ~-phorbol-12-tetradeca- 
noate-13-acetate (TPA, fig. Id) shows that the two 
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Fig.1. Space-filling molecular models, positioned so as 
to bring out the congruity of the hydrogen bond 
donating and receiving groups involved in bonding to 
the diglyceride (DG)-receiving site of protein kinase C. 
All molecules were initially constructed as skeletal 
Dreiding models for verification of conformation and 
assessment of steric hindrance and strain effects, 
following published, sterically explicit structures 
[32-341. The numbers refer to the carbon atoms to 
which the oxygen atoms in question are bound. The 
triangles (which have no physical meaning) serve to 
demonstrate the possibility of congruity between the 
hydrogen bonding patterns of the five molecules. (a) 
PIPI, phosphatidylinositol bisphosphate, precursor to 
DG; (b) DG, diglyceride; (c) A-toxin, aplysiatoxin; (d) 
TPA, phorbol-12-tetradecanoate-13-acetate. The di- 
methylcyclopropane group of this molecule could not be 
constructed with the available space-filling model set; a 
Dreiding molecular model showed that this group 
projects to the back of the model as shown here and does 
in no way interfere with the face shown. Note the steric 
restriction of the hydrogen bond donor [9] to bonding in 
directions between 5 and 9 o’clock only, and the 
protective hydrophobic domain in its back. As for the 
possibility of 4&OH rather than 9~OH being the 
required hydrogen bond donor, see the text. (e) TC, 
teleocidin. The 0 = atom corresponding to position .sn-1 
in DG is replaced here by a tertiary amino group [13], a 
hydrogen bond acceptor by virtue of its lone electron 
pair. 
ester = 0 oxygens on C-12 and 13 and the 9cu-OH 
group are superposable on the DG structure, not 
only in their position but also in the direction of 
the hydrogen bonds: coming in from the viewer 
onto the center of the =0 atoms, pointing west 
(the hook) from the proton of the 9-OH group. 
Even the positioning of hydrogen atoms in the ac- 
tive oxygen triangle is similar. The models (fig. 
lb,d) also offer a suggestion as to why phorbol 
diester has a much higher affinity, maybe lOOO- 
fold, for the kinase than the proper effector, DC; 
in DG, which has a mobile, primary hydroxyl, the 
sn-3-OH - +. protein hydrogen bond may have to 
compete with hydrogen bonding to and from 
water, and the 0 atom of the M-~-OH may be 
susceptible to enzymic phosphorylation (possibly 
the mechanism of DG deactivation). In the phor- 
bol diester, however, the 9-OH group sits in a 
hydrophobic pocket, where it can rotate only from 
5-9 o’clock (fig. Id) with its back safely protected 
by a hydrophobic niche. 
It must be mentioned that the possibility cannot 
be discarded that the W-OH (not visible in our 
projection) rather than the 9cr-OH is the H-donor 
used in the DG-receiving site; it appears that inver- 
sion in position 4, or methylation of 4-OH, 
destroys the kinase-activating faculty of phorbol 
ester [16]. On the other hand, deoxygenation at 4 
is reported to leave the biological activity intact 
[17]; it is likely, therefore, that the 4-OH has some 
steric influence on phorbol-kinase bonding but 
does not itself bond to the DG-receiving site. In a 
model, the ester = 0 oxygens and the &-OH can 
(in the back of the model of fig.ld) form a 
triangular pattern resembling that involving 9~ 
OH, except for the bulky intrusion of a 
dimethylcyclopropane group into the triangle of 
oxygens. This steric hindrance, and a lack of com- 
plete congruity with the effector sites of the re- 
maining molecules of fig. 1, argue for 9-12-13 
rather than 4-12-13 constituting that site. A final 
decision cannot yet be made, and is not necessary 
for the argument: either configuration allows for 
the two-acceptor-one-donor hydrogen bond 
arrangement. 
In two other, tumor-promoting, kinase- 
activating compounds there is no chance for 
spatial duplicity. Aplysiatoxin [ 18,191 (fig. lc) 
proffers the same familiar arrangement of one OH 
and two = 0 groups. Teleocidin [18-211 (fig. le) 
possesses only one CO (corresponding to the 
sn-ZCO of DG); a tertiary amino group in posi- 
tion 13 stands in for the other = 0, with the lone 
electron pair accepting the hydrogen bond; and the 
OH group is in its expected place. 
The kinase-DG interaction presents a clear case 
of protein-lipid hydrogen bonding (regardless of a 
possible future revision of tumor promotor- 
enzyme bond assignments). For some other cases, 
e.g. the interaction of steroids with their receptors, 
the existence of such bonding is also incontestable; 
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but protein-lipid hydrogen bonding is rarely con- 
ceived as a feature common to all membrane ar- 
chitecture. Evidence has been presented [22] for 
one membrane nzyme, glucose-6-phosphatase: its
activity, and thus its conformation, depends on the 
composition of the membrane ‘hydrogen belts’ 
[23-251, i.e. those strata of the membrane contain- 
ing hydrogen bond acceptors (CO of phos- 
pholipids) and donors (OH of cholesterol, sphin- 
gosine, proteins) (fig.2). The evidence collected 
here for the kinase C is more direct, and con- 
clusive. Admittedly, free diacylglycerol is only 
a minor and transient component of the lipid 
bilayer; but as a common moiety of nearly all 
phospholipids it is the most prominent of all its 
building blocks. Fig.la shows the precursor of free 
DG [26-281, phosphatidylinositol bisphosphate 
(PIPz): in this lipid, as in all phosphoglycerides, 
the m-3 OH is blocked, but the m-1 and m-2 = 0 
atoms are already available for hydrogen bonding 
from a membrane protein (and it might be 
speculated that a hydrogen-bonded PIP?-protein 
kinase complex is the direct precursor of the DG- 
protein kinase complex). It does not seem 
reasonable to expect that glucose-6-phosphatase 
and protein kinase C are the only existing proteins 
that can engage in hydrogen bonding to membrane 
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Fig.2. Schematic model of a plasma membrane. The 
isolated lines represent aliphatic chains of lipids or 
hydrophobic peptides. The shaded rectangles are 
cholesterol; C, carbohydrates; + and - , charged lipid 
headgroups and amino acids. Besides lipid-lipid bonding 
in the hydrogen belts, hydrophobic lipid-protein 
bonding in the hydrophobic core, and ionic lipid-protein 
bonding in the polar zones, the model proposes 
hydrogen bonding from proteins to lipids taking place in 
the hydrogen belts (from (231). 
lipids; it would seem more likely that many, even 
most, membrane-associated proteins make use not 
only of hydrophobic bonding but also of hydrogen 
bonding to maintain their place in the bilayer. This 
has been suggested in fig.2. A thermodynamic 
argument can also be made for such bonding. The 
hydrophobic bonding energy between an average 
fatty acid ester and a completely hydrophobic pep- 
tide is around 12 kcal/mol [29]. Addition of a 
hydrogen bond between peptide and fatty ester CO 
would add another 3-6 kcal (the -AC of an O- 
H . ..O bond [30,31]), i.e. such hydrogen bonding 
might contribute up to 33% of the energy keeping 
the protein in the membrane. Even more drastic, 
a bobbing of the protein vertical to the bilayer with 
an amplitude of one average bond length would 
make a difference of 0.8 kcal/mol fatty ester (the 
value of -A G for hydrophilic-lipophilic transfer 
of one CH2 group [29]); but if such bobbing would 
require the breaking of hydrogen bonds to the fat- 
ty esters, the bonding energy lost could be 6-times 
larger. In view of such a thermodynamic advan- 
tage it would be odd if protein-lipid hydrogen 
bonding were not made use of in the hydrogen 
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